Log In
BCIQ
Print this Print this
 

gilteritinib (ASP2215)

  Manage Alerts
Collapse Summary General Information
Company Astellas Pharma Inc.
DescriptionSmall molecule AXL receptor tyrosine kinase (AXL; UFO) and FMS-like tyrosine kinase 3 (FLT3; CD135) inhibitor
Molecular Target AXL receptor tyrosine kinase (AXL) (UFO) ; FMS-like tyrosine kinase 3 (FLT3) (CD135)
Mechanism of ActionFMS-like tyrosine kinase 3 (FLT3) inhibitor; AXL receptor tyrosine kinase (AXL) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/28/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today